Diltiazem controlled release formulation and method of...

Details Diltiazem controlled release formulation and method of... Diltiazem controlled release formulation and method of...

A - Human Necessities

61

K

A61K 9/26 (2006.01) A61K 31/554 (2006.01)

Patent

CA 2617351

A controlled release diltiazem dosage formulation comprising a plurality of diltiazem pellets and a gel-forming material where the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration and preferably more than 10 hours after administration.

L'invention concerne une formulation à libération contrôlée de doses de diltiazem qui renferme une pluralité de pellets ainsi qu'un matériau gélifiant, les concentrations maximales de diltiazem dans le plasma sanguin se produisant 8 heures, et préférablement plus de 10 heures, après administration.

Affiliated with

Also associated with

Rating

Diltiazem controlled release formulation and method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diltiazem controlled release formulation and method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diltiazem controlled release formulation and method of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1420492